-
Impact of Severe Postoperative Complications and P-POSSUM Score on Oncological Outcomes in Primary Retroperitoneal Sarcoma: Insights from a Tertiary Cancer Center
-
ADAM Proteases in Cancer: Biological Roles, Therapeutic Challenges, and Emerging Opportunities
-
Molecular Characterization of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma
Journal Description
Cancers
- Open Access— free for readers, with article processing charges (APC) paid by authors or their institutions.
- High Visibility: indexed within Scopus, SCIE (Web of Science), PubMed, PMC, Embase, CAPlus / SciFinder, and other databases.
- Journal Rank: JCR - Q2 (Oncology) / CiteScore - Q1 (Oncology)
- Rapid Publication: manuscripts are peer-reviewed and a first decision is provided to authors approximately 20.3 days after submission; acceptance to publication is undertaken in 2.6 days (median values for papers published in this journal in the first half of 2025).
- Recognition of Reviewers: reviewers who provide timely, thorough peer-review reports receive vouchers entitling them to a discount on the APC of their next publication in any MDPI journal, in appreciation of the work done.
- Sections: published in 18 topical sections.
- Companion journals for Cancers include: Radiation and Onco.
- Journal Clusters of Oncology: Cancers, Current Oncology, Onco and Targets.
Latest Articles
Highly Accessed Articles
Latest Books
E-Mail Alert
News
Meet Us at the United European Gastroenterology Week Berlin 2025, 4–7 October 2025, Berlin, Germany

Meet Us at the 5th International Symposium on Frontiers in Molecular Science, 26–29 August 2025, Kyoto, Japan

Topics
Deadline: 20 August 2025
Deadline: 31 August 2025
Deadline: 16 October 2025
Deadline: 31 October 2025
Conferences
Special Issues
Deadline: 30 July 2025
Deadline: 30 July 2025
Deadline: 30 July 2025
Deadline: 30 July 2025